2025年，无疑是量化投资发展史上一个标志性的大年。年初，DeepSeek的横空出世为量化领域注入了颠覆性的AI动能；与此同时，A股市场震荡上行，整 体而言中小盘风格显著占优，中证2000与微盘股指数分别大涨超36%和80%，叠加市场流动性充裕、交投活跃，多重利好共振，令量化多头策略"如鱼得 水"，迎来全面爆发！ 为能更清晰了解量化私募基金的业绩，经笔者统计，在私募排排网上有业绩展示的量化产品共有1784只，2025年平均收益达30.28%，2025年平均超额 （几何）收益达10.83%；其中量化多头策略产品多达806只，2025年收益和超额（几何）收益分别为44.74%、16.46%，在私募二级策略中居前。 | 排 | 私募二级策略 | 有业绩展示的 | 2025年平均收益 | 2025 E 24 2 | | --- | --- | --- | --- | --- | | 序 | | 量化产品 | | 超额收益 | | 1 | 喜化多杀 | 806 | 44.74% | 16.46% | | 2 | 量化CTA | 375 | 20.21% | 14.04% | | 3 | 股票市场中性 | 186 | 9 ...

Group 1 - The core viewpoint is that with the increasing variety of index investment tools, fund companies need to seek differentiated index product development paths [1] - The company is committed to creating a product system with long-term allocation value and research-added value in the development of specialized indices [1] - The company emphasizes a customer-centric approach, embedding investor needs throughout the product lifecycle and focusing on the investor's holding experience [1] Group 2 - The company has established a business layout that includes three core product lines: broad-based ETFs, index enhancement, and specialized indices [1] - The index enhancement products cover indices such as the CSI 300 Index, CSI 500 Index, and CSI 1000 Index [1] - The specialized index products include the CSI Selected 300 Index, while the broad-based ETF products consist of the CSI 300 ETF and CSI A500 ETF [1]

Core Viewpoint - Lingjun Investment has faced significant challenges following regulatory measures in early 2024, prompting a deep reflection and reform in its operational and governance structures to ensure survival and competitiveness in the quantitative investment industry [2][3][4]. Group 1: Company Challenges and Reforms - The company experienced its most severe crisis since its establishment due to the "2·19 incident," which led to a three-day trading restriction on its products [2][3]. - In response to the crisis, Lingjun Investment initiated comprehensive reforms focusing on cultural and governance improvements, establishing a "co-management + specialization" collaborative mechanism [3][4]. - The leadership structure was redefined, with Cai Meijie overseeing cultural and governance aspects while Ma Zhiyu focused on research and investment strategies [4]. Group 2: Compliance and Risk Management Enhancements - The company has implemented a systematic overhaul of its compliance and risk management frameworks, embedding risk control parameters into all trading strategies to ensure adherence to regulatory requirements [5][6]. - A dual-layered risk control mechanism has been established, integrating strategy-level controls with comprehensive system-level rules to mitigate risks effectively [6][7]. - All trading activities are now monitored under a unified risk management framework, allowing for cross-product risk analysis and compliance oversight [6]. Group 3: Focus on Fundamental Factor Research - Lingjun Investment has been deepening its research into fundamental factors since 2015, recognizing their growing importance in evaluating corporate value and enhancing strategy resilience [8][9]. - The company aims to expand its fundamental factor research by exploring new industry-specific factors and refining existing ones to improve their quality and effectiveness [9]. Group 4: Performance and Strategy Adjustments - The quantitative strategies of Lingjun Investment have shown strong performance, with average returns of 11.50% and 14.85% for private equity quantitative stock selection strategies and the CSI 1000 index enhancement strategy, respectively, in the first half of the year [10]. - The company has adjusted its product line to focus on its leading quantitative stock selection strategies while also expanding its index enhancement products to meet diverse investor needs [10][11]. - Recent strategy upgrades have balanced long-term signals with short-term predictive capabilities, enhancing the company's adaptability to market fluctuations and contributing to its strong performance [11].